@article {Zhaoannrheumdis-2021-220759, author = {Yan Zhao and Jin-Xian Huang}, title = {Correspondence on {\textquoteleft}Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomized, placebo-controlled, phase 3 trial{\textquoteright}}, elocation-id = {annrheumdis-2021-220759}, year = {2021}, doi = {10.1136/annrheumdis-2021-220759}, publisher = {BMJ Publishing Group Ltd}, issn = {0003-4967}, URL = {https://ard.bmj.com/content/early/2021/06/25/annrheumdis-2021-220759}, eprint = {https://ard.bmj.com/content/early/2021/06/25/annrheumdis-2021-220759.full.pdf}, journal = {Annals of the Rheumatic Diseases} }